Clarksville Mayor Joe Pitts plans to end the lease for the Ajax Turner 50+ Center over safety concerns, leaving members and ...

Eli Lilly is stepping further into oncology with an agreement to acquire closely held Ajax Therapeutics for up to $2.3 billion in cash, a ...

USA Rare Earth will buy a Brazilian mine to secure supply of heavy rare earths outside of Asia.

Britain resumes acceptance of Ajax armoured vehicles from General Dynamics after safety improvements, keeping within existing ...

Ajax deal expands Lilly’s oncology pipeline; Hematology focus adds depth beyond GLP therapies; Healthcare strategy gains ...

Eli Lilly (NYSE:LLY) agreed to acquire Ajax Therapeutics for up to $2.3b, adding a Type II JAK2 inhibitor program for ...

Indianapolis-based drug giant Eli Lilly and Co. on Monday announced an agreement to acquire cancer-drug developer Ajax ...

Lilly will pay up to $2.3B for Ajax and its AJ1‑11095 myelofibrosis drug; proof‑of‑concept data expected in 2026.

Eli Lilly (LLY) acquires Ajax Therapeutics for $2.3B, adding AJ1-11095, a novel JAK2 inhibitor for myelofibrosis and blood ...

Total consideration reaches up to $2.3 billion via upfront payment plus milestones tied to predefined clinical and regulatory ...

Eli Lilly and Company and Ajax Therapeutics, Inc. ("Ajax"), a biopharmaceutical company developing next generation JAK inhibitors for patients with myeloproliferative neoplasms (MPNs), today announced ...

Eli Lilly to acquire Ajax Therapeutics for up to $2.3B, boosting blood cancer pipeline with a Phase 1 JAK2 inhibitor for ...